Sana Biotechnology Inc (NAS:SANA)
$ 6.91 -0.06 (-0.86%) Market Cap: 1.53 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 4.07 GF Score: 39/100

Sana Biotechnology Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 06:30PM GMT
Release Date Price: $12.56 (+2.11%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good afternoon from the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce Sana Biotechnology and CEO, Steve Harr. Please note that following this presentation, we will move right into a Q&A session. (Operator Instructions) So with that, Steve, thanks for joining us today. Let me turn things over to you for an update.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

Thank you, Cory, and thank you, everybody, for joining us today. We'll be making some forward-looking statements today, as you might imagine. So please do take a look at our 10-Q and 10-K. We spent a lot of time on the risk factors, so hope you'll find that useful.

So Sana was founded with the belief that one of, if not the most important transformation that will occur in medicine over the next several decades, is the ability to modulate genes and use cells as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot